Intracameral concentrations of the fibrinolytic system components in patients with age-related macular degeneration.

• Conditions: H35.3; Degeneration of macula and posterior pole

• Registration Number: DRKS00004679
• Lead Sponsor: KGM GmbH, Standort Marburg, Augenklinik

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2011-02-01
• Study Start: 2013-01-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 93

Inclusion Criteria

age-related macular degeneration, cataract

Exclusion Criteria

neoplasias
high myopia
patient younger 40 years
other eye diseases (diabetic retinopathy, h/o retinal detachment, uveitis, glaucoma)

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Detection of intrcameral plasminogen activity

Secondary Outcome Measures

Name	Time	Method
Detection of concentrations and activities of different fibrinolytic system components.<br>(Plasminogen-activator-inhibitor I (PAI-1), alpha2-antiplasmin, plasmin-a2-antiplasmin complex (PAP) )